PackTalk is a blog for the Healthcare Packaging Industry

Clinical Trials in Europe Show Promise for Treatment of COVID-19


Published on April 17, 2020

Roche Phase III Covid-19 clinical trial is under way, as United Kingdom Prime Minister Boris Johnson continues his recovery from the novel coronavirus.

As the UK responds to high numbers and their own PM’s brush with death from Covid-19, it is clear no greater need exists than to see approval of life-saving treatments available to the worldwide market. Roche continues to be a major player as the pharmaceutical industry works with global regulatory leaders in the fight against the pandemic.

In March, Pharma Times reported that Roche was approved (with French partner Sanofi, Eusa Pharma and US-based Regeneron) to undertake a Phase III clinical trial (COVACTA). Enrollment of 330 patients from across the world began in early April, with six patients enrolled to date from Spain and the US. Eligible patients must be hospitalized with “severe” Covid-19 pneumonia to be considered for the FDA-backed trial.

Actemra/RoActemra has previously been claimed as part of China’s Covid-19 treatment plan, published by the NHC on March 3, 2020. Existing independent studies for the drug’s use with Covid-19 patients offer limited published findings, such as a three-patient report of major improvement from a Naples, Italy hospital that was then tried at other Italian hospitals. This will be the first well-controlled, global study to clinically examine safety and efficacy. The trial paves the way to confirm or disprove Actemra/RoActemra as a viable treatment for patients suffering serious cases of Covid-19.

Read more here:

 


Comments (0)

Related Articles

The Healthcare Digital Revolution

January 23, 2021

In 1972, the Regenstreif Institute proudly rolled out the first electronic medical records (EMRs) to physician practices. The electronic forms touted the ability to centralize data, reduce or eliminate paper files, and access data from multiple computer...

Learn More

ISO 11040-7: Packaging In-Process Pharma and Prefilled Syringe Tubs

January 23, 2021

For those in the medical device and healthcare packaging industries, whether you are just starting out or have been in the field for 30 years like me, we understand ISO 11607. We live and breathe it every day. Whether we are considering the device itself, the...

Learn More

Design for Manufacture: Saving billions for more than 40 years

January 23, 2021

The medical packaging industry is unique—it requires extreme attention to detail and the ability to think outside the norm when designing. Yet, because packaging engineers are well aware of the hurdles that must be cleared to reach the market, it is also easy...

Learn More

Stay Informed

To stay up to date on innovative technology and products, as well as industry trends, subscribe to Oliver’s PackTalk blog below.